← Back to headlines
Sanofi's MenQuadfi Approved in EU for Infant Meningococcal Disease
Sanofi's MenQuadfi vaccine has received approval in the European Union for use in infants to protect against meningococcal disease.
4 Aug, 09:12 — 4 Aug, 09:12
Sources
Showing 1 of 1 sources
Related Stories
Rhine River Shipping Faces Challenges Due to Low Water Levels
15m ago
Norganic recalls Spirefrø product due to E. coli contamination
16m ago
UFC Event with Trump Incurs $30 Million Loss, Generates $1 Billion Media Exposure
16m ago
Miroslav Remeta's Business Empire Faces Collapse Amid Debts and Project Failures
17m ago